1. | nomaam4565 | |
2. | pierceton | |
3. | dianamoonblade1 | |
4. | SugarDaddy | |
5. | nshsn8vjkdpyvqf |
1. | nomaam4565 | |
2. | pierceton | |
3. | dianamoonblade1 | |
4. | SugarDaddy | |
5. | nshsn8vjkdpyvqf |
1. | SugarDaddy 02/21/2018 Announces positive top-line results from Phase 3 study |
2. | dianamoonblade1 02/05/2018 Granted orphan drug designation by the FDA for Imbruvica for the treatment of gastric cancer, including gast… |
3. | SugarDaddy 10/18/2017 {Image} |
4. | dianamoonblade1 03/27/2018 Chicago jury has ordered AbbVie to pay a man $3M who claimed the company misrepresented the risks of its tes… |
5. | pierceton 01/26/2018 AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results |
6. | pierceton 01/26/2018 ABBV leads the way today as the best performing large cap stock, closing up 13.77%. |
7. | dianamoonblade1 02/18/2018 AbbVie Announces New Phase 2 Data for Upadacitinib Showing Clinical and Endoscopic Outcomes in Crohn's Disease at 52 Weeks |
8. | nomaam4565 03/22/2018 The company's massive Rova-T program has delivered disappointing results. |
9. | nomaam4565 07/27/2018 Sees FY18 EPS $7.76-7.86 (Prior $7.66-7.76) |
10. | SugarDaddy 07/24/2018 Receives FDA approval of ORILISSA (elagolix) for the management of moderate to severe pain |